Zoetis Inc receives Investment Bank Analyst Rating Update
Zoetis (NYSE:ZTS) is pleased to receive a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate innovative solutions to advance veterinary...
By Davit Kirakosyan Loop Capital upgraded Upstart Holdings Inc (NASDAQ:UPST) to Buy from Hold with a price target of $24.00 as the firm believes shares have reached a level...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Many people have marked Valentine's Day, Feb. 14, on their calendars. The annual festivity has evolved to one of the year’s most lucrative shopping seasons in the US....
The final week of November brought increased volatility to broader markets. But when looking at the year as a whole, so far the Dow Jones, the S&P 500 and the NASDAQ 100 are up...
Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. It commercializes products across eight core species: dogs, cats and horses and cattle, swine, poultry, fish and sheep and within product categories, such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. It operates through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers, including Alfaxan. The Company market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.
|Average||214.92 (+29.13% Upside)|
|No. of Analysts||16|
|Moving Averages||Strong Buy||Strong Buy||Strong Buy||Strong Buy||Buy|
|Technical Indicators||Strong Buy||Strong Buy||Strong Buy||Strong Buy||Sell|
|Summary||Strong Buy||Strong Buy||Strong Buy||Strong Buy||Neutral|